Johnson Matthey PLC (LON:JMAT) Receives GBX 2,341.67 Consensus Target Price from Analysts

Shares of Johnson Matthey PLC (LON:JMATGet Rating) have been assigned a consensus recommendation of “Hold” from the seven analysts that are currently covering the stock, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is GBX 2,341.67 ($28.29).

A number of research firms have issued reports on JMAT. Barclays reissued an “equal weight” rating and set a GBX 2,110 ($25.50) price target on shares of Johnson Matthey in a research report on Friday, May 27th. Berenberg Bank restated a “buy” rating and set a GBX 2,550 ($30.81) price objective on shares of Johnson Matthey in a research note on Friday, May 27th. Citigroup restated a “neutral” rating and set a GBX 2,200 ($26.58) price objective on shares of Johnson Matthey in a research note on Friday, August 12th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on Johnson Matthey from GBX 2,000 ($24.17) to GBX 2,300 ($27.79) and gave the stock a “hold” rating in a research note on Sunday, May 29th.

Johnson Matthey Price Performance

JMAT stock opened at GBX 2,008 ($24.26) on Thursday. The stock has a 50-day moving average price of GBX 2,070.56 and a two-hundred day moving average price of GBX 2,030.20. Johnson Matthey has a 12-month low of GBX 1,650 ($19.94) and a 12-month high of GBX 2,875 ($34.74). The company has a current ratio of 1.33, a quick ratio of 0.68 and a debt-to-equity ratio of 51.33. The company has a market cap of £3.68 billion and a PE ratio of 3,291.80.

Insider Buying and Selling

In other Johnson Matthey news, insider Stephen Oxley purchased 15 shares of the business’s stock in a transaction that occurred on Wednesday, August 17th. The shares were acquired at an average price of GBX 2,219 ($26.81) per share, for a total transaction of £332.85 ($402.19).

About Johnson Matthey

(Get Rating)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources.

Read More

Analyst Recommendations for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.